ATAI Life Sciences BV Cash Flow Reinvestment Rate
Latest as of June 2021:
14.68x
ATAI Life Sciences BV cash flow reinvestment rate. ATAI Life Sciences BV (ATAI) has a Cash Flow Reinvestment Rate of 14.68x as of June 2021, reinvesting $27.85 Million (capex $278.00K plus investments $-27.57 Million) from operating cash flow of $1.90 Million. Explore ATAI Life Sciences BV (ATAI) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
14.68x
(Capex + Investments) / Operating CF
Total Reinvested
$27.85 Million
Capex + Investments
Operating Cash Flow
$1.90 Million
USD
Capital Expenditures
$278.00K
USD
ATAI Life Sciences BV Cash Flow Reinvestment Rate by Year (None–None)
ATAI Life Sciences BV cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for ATAI Life Sciences BV. For the full cash flow conversion analysis, see ATAI cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow